Antibiotic-Free Selection in Biotherapeutics: Now and Forever
Open accessThe DOI matches its Crossref record; 110 of the 110 references it cites were found in a registry or an index.
Abstract
The continuously improving sophistication of molecular engineering techniques gives access to novel classes of bio-therapeutics and new challenges for their production in full respect of the strengthening regulations. Among these biologic agents are DNA based vaccines or gene therapy products and to a lesser extent genetically engineered live vaccines or delivery vehicles. The use of antibiotic-based selection, frequently associated with genetic manipulation of microorganism is currently undergoing a profound metamorphosis with the implementation and diversification of alternative selection means. This short review will present examples of alternatives to antibiotic selection and their context of application to highlight their ineluctable invasion of the bio-therapeutic world.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“The global health agencies (FDA, EMA, WHO) also discourage the use of β-lactams (i.e., ampicillin, penicillin) and streptomycin resistance genes in plasmids for gene therapy [227].”
From Recombinant Adeno-Associated Viral Vectors (rAAV)-Vector Elements in Ocular Gene Therapy Clinical Trials and Transgene Expression and Bioactivity Assays (2020) · cites this paper as [227]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products
Datsenko, K. A., & Wanner, B. L. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.120163297 · Cited by 14,782 · cited 1×
“To produce a recombinant protein, a way to avoid the antibiotic resistance marker is to integrate the gene of interest into bacterial chromosome [83].”
BackgroundMolecular mechanisms of antibiotic resistance
Blair, J. M. A., Webber, M. A., Baylay, A. J., Ogbolu, D. O., & Piddock, L. J. V. (2015) · Nature Reviews Microbiology · doi:10.1038/nrmicro3380 · Cited by 4,092 · cited 1×
“It becomes clear that antibiotic-resistant bacteria are causing a global health crisis and that mechanisms behind acquisition of resistance are more and more documented [8].”
BackgroundHerrero, M., de Lorenzo, V, & Timmis, K. N. (1990) · Journal of Bacteriology · doi:10.1128/jb.172.11.6557-6567.1990 · Cited by 1,586 · cited 1×
“[54]”
Gene therapy clinical trials worldwide to 2012 – an update
Ginn, S. L., Alexander, I. E., Edelstein, M. L., Abedi, M. R., & Wixon, J. (2013) · The Journal of Gene Medicine · doi:10.1002/jgm.2698 · Cited by 1,159
Wiedenbeck, J., & Cohan, F. M. (2011) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2011.00292.x · Cited by 663 · cited 1×
“More recently, acquisition of the virulence factors that distinguish Salmonella from Escherichia coli has been clearly shown as the result of horizontal gene transfer [13].”
BackgroundMini-F plasmid genes that couple host cell division to plasmid proliferation.
Ogura, T., & Hiraga, S. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.15.4784 · Cited by 575 · cited 2×
“These authors also put in evidence that the combination SopA, SopB and SopC was not sufficient for a complete stabilization of mini-F plasmid, and thus identified the additional element ccd (control of cell death) region that seemed crucial to control cell division when copy number carrying ccd segment decreases [18].”
BackgroundPenicillinase Synthesis Controlled By Infectious R Factors In Enterobacteriaceae
DATTA, N., & KONTOMICHALOU, P. (1965) · Nature · doi:10.1038/208239a0 · Cited by 569 · cited 1×
“As early as in 1965, Datta and Kontomichalou [11] showed the widespread transfer of penicillin resistance across Enterobacteriaceae.”
BackgroundSummers, D. K., & Sherratt, D. J. (1984) · Cell · doi:10.1016/0092-8674(84)90060-6 · Cited by 452 · cited 1×
“Concerning plasmid maintenance, it has been shown that factors reducing multimerization of plasmid could increase plasmid stability [24].”
BackgroundNikol, S., Baumgartner, I., Van Belle, E., Diehm, C., Visoná, A., Capogrossi, M. C., Ferreira-Maldent, N., Gallino, A., Graham Wyatt, M., Dinesh Wijesinghe, L., et al. (2008) · Molecular Therapy · doi:10.1038/mt.2008.33 · Cited by 333 · cited 1×
“First human phase I and II clinical trials using plasmid pCOR encoding fibroblast growth factor 1 have suggested an improvement of perfusion and an increase in amputation free survival in patients with critical limb ischemia [98].”
BackgroundA robust system for production of minicircle DNA vectors
Kay, M. A., He, C.-Y., & Chen, Z.-Y. (2010) · Nature Biotechnology · doi:10.1038/nbt.1708 · Cited by 329 · cited 1×
“Cre recombinase [87] or ΦC31 integrase [65,68].”
Gerdes, K., Bech, F. W., Jørgensen, S. T., Løbner-Olesen, A., Rasmussen, P. B., Atlung, T., Boe, L., Karlstrom, O., Molin, S., & von Meyenburg, K. (1986) · The EMBO Journal · doi:10.1002/j.1460-2075.1986.tb04459.x · Cited by 288 · cited 1×
“the parB locus, also identified as hok/sok, is used for plasmid maintenance since 1986 [44] and have also been combined with parDE [45].”
BackgroundChromosome position effects on gene expression in Escherichia coli K-12
Bryant, J. A., Sellars, L. E., Busby, S. J. W., & Lee, D. J. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku828 · Cited by 286 · cited 1×
“[85] have shown that expression of gfp may vary by around 300-fold depending on its precise position on the chromosome of E.”
BackgroundEffects of the ccd function of the F plasmid on bacterial growth
Jaffé, A., Ogura, T., & Hiraga, S. (1985) · Journal of Bacteriology · doi:10.1128/jb.163.3.841-849.1985 · Cited by 277 · cited 1×
“[19], demonstrated that cell division is not immediately inhibited and that residual division could take place in the plasmid free-cells before finally being inhibited.”
BackgroundTADB: a web-based resource for Type 2 toxin–antitoxin loci in bacteria and archaea
Shao, Y., Harrison, E. M., Bi, D., Tai, C., He, X., Ou, H.-Y., Rajakumar, K., & Deng, Z. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkq908 · Cited by 254 · cited 1×
“Among the numerous toxin/antitoxin identified and recently referenced into the TADB database [77], two have been investigated for applications in biotechnology.”
BackgroundA new DNA vehicle for nonviral gene delivery: supercoiled minicircle
Darquet, A.-M., Cameron, B., Wils, P., Scherman, D., & Crouzet, J. (1997) · Gene Therapy · doi:10.1038/sj.gt.3300540 · Cited by 249 · cited 1×
“Minicircle generation can be done using lambda integrase [86],”
BackgroundGeorghiou, S. B., Magana, M., Garfein, R. S., Catanzaro, D. G., Catanzaro, A., & Rodwell, T. C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033275 · Cited by 249 · cited 1×
“[7] The gene neomycin phosphotransferase III [npt-III, aph(3')-III] should be avoided, since it also confers resistance to amikacin [17], a reserve antibiotic (EMEA, 2008).”
BackgroundGalán, J. E., & Curtiss, R. (1991) · Infection and Immunity · doi:10.1128/iai.59.9.2901-2908.1991 · Cited by 244 · cited 1×
“[33]”
Evaluating metabolic stress and plasmid stability in plasmid DNA production by Escherichia coli
Silva, F., Queiroz, J. A., & Domingues, F. C. (2012) · Biotechnology Advances · doi:10.1016/j.biotechadv.2011.12.005 · Cited by 227 · cited 1×
“have suggested possible evolution of fermentation methods towards online bioprocess monitoring to circumvent metabolic burden and plasmid instability [29].”
MethodHorizontal gene transfer in human pathogens
Juhas, M. (2015) · Critical Reviews in Microbiology · doi:10.3109/1040841x.2013.804031 · Cited by 222 · cited 1×
“Horizontal genetic transfer (HGT), an important driving force in bacterial evolution, is the passage of genetic elements between organisms [9,10].”
BackgroundMwau, M., Cebere, I., Sutton, J., Chikoti, P., Winstone, N., Wee, E. G.-T., Beattie, T., Chen, Y.-H., Dorrell, L., McShane, H., et al. (2004) · Journal of General Virology · doi:10.1099/vir.0.19701-0 · Cited by 207 · cited 1×
“The pORT vector was chosen to develop a HIV-1 DNA vaccine, and its delivery induced a specific immune response in patients [99].”
MethodStable inheritance of plasmid R1 requires two different loci
Gerdes, K., Larsen, J. E., & Molin, S. (1985) · Journal of Bacteriology · doi:10.1128/jb.161.1.292-298.1985 · Cited by 184 · cited 1×
“Plasmid R1 has also been shown to contain a stabilization system [20].”
BackgroundUlmer, J. B., Mason, P. W., Geall, A., & Mandl, C. W. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.04.060 · Cited by 181
Chen, Z.-Y., He, C.-Y., & Kay, M. A. (2005) · Human Gene Therapy · doi:10.1089/hum.2005.16.126 · Cited by 180 · cited 1×
“Cre recombinase [87] or ΦC31 integrase [65,68].”
Multiple hok genes on the chromosome of Escherichia coli
Pedersen, K., & Gerdes, K. (1999) · Molecular Microbiology · doi:10.1046/j.1365-2958.1999.01431.x · Cited by 170 · cited 1×
“Hok protein orthologs are also found in the genomes of Enterobacteria [21–23].”
BackgroundEvaluation of a prototype dengue-1 DNA vaccine in a Phase 1 clinical trial
Beckett, C. G., Tjaden, J., Burgess, T., Danko, J. R., Tamminga, C., Simmons, M., Wu, S.-J., Sun, P., Kochel, T., Raviprakash, K., et al. (2011) · Vaccine · doi:10.1016/j.vaccine.2010.11.050 · Cited by 160 · cited 1×
“However, evaluation of a DNA dengue-1 vaccine in a phase I trial by an naval medical research center was still based on a VR1012 plasmid backbone containing kanamycin resistance [97].”
BackgroundNuttall, S. D., Krishnan, U. V., Hattarki, M. K., Gori, R. D., Irving, R. A., & Hudson, P. J. (2001) · Molecular Immunology · doi:10.1016/s0161-5890(01)00057-8 · Cited by 159 · cited 1×
“[58],”
Baumgärtner, F., Seitz, L., Sprenger, G. A., & Albermann, C. (2013) · Microbial Cell Factories · doi:10.1186/1475-2859-12-40 · Cited by 152 · cited 1×
“[64]”
Bigger, B. W., Tolmachov, O., Collombet, J.-M., Fragkos, M., Palaszewski, I., & Coutelle, C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010873200 · Cited by 149 · cited 1×
“Cre recombinase [87] or ΦC31 integrase [65,68].”
Summers, D., & Sherratt, D. J. (1988) · The EMBO Journal · doi:10.1002/j.1460-2075.1988.tb02884.x · Cited by 143 · cited 1×
“boundaries in terms of length and the apparent poorly conserved sequence among multimer resolution sites [25].”
BackgroundLemuth, K., Steuer, K., & Albermann, C. (2011) · Microbial Cell Factories · doi:10.1186/1475-2859-10-29 · Cited by 140 · cited 1×
“[63], using a plasmid-free Escherichia coli strain to produce the xanthophyll astaxanthin, a high-value compound with applications in the nutraceutical, cosmetic, food, and animal feed industries.”
MethodSelf-replicating alphavirus RNA vaccines
Ljungberg, K., & Liljeström, P. (2015) · Expert Review of Vaccines · doi:10.1586/14760584.2015.965690 · Cited by 137 · cited 1×
“After long and disappointing results, this technique recently entered a new era with the advent of self-replicating RNA viruses [103].”
The impact of horizontal gene transfer on the adaptive ability of the human oral microbiome
Roberts, A. P., & Kreth, J. (2014) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2014.00124 · Cited by 133 · cited 1×
“Moreover, if we consider the situation at the microbiome level, it becomes obvious that a multitude of different bacterial species, exhibiting many types of complex interactions, are likely to use HGT as a preponderant mechanism for adaptation in difficult environment [15].”
BackgroundCranenburgh, R. M. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.5.e26 · Cited by 132 · cited 1×
“This pORT plasmid strategy is based on “operator repressor titration” (see Table 1) [100].”
MethodGalen, J. E., Nair, J., Wang, J. Y., Wasserman, S. S., Tanner, M. K., Sztein, M. B., & Levine, M. M. (1999) · Infection and Immunity · doi:10.1128/iai.67.12.6424-6433.1999 · Cited by 122 · cited 1×
“[47]”
Tacket, C. O., Kelly, S. M., Schödel, F. P., Losonsky, G. A., Nataro, J. P., Edelman, R., Levine, M. M., & Curtiss, R. (1997) · Infection and Immunity · doi:10.1128/iai.65.8.3381-3385.1997 · Cited by 119
Improved antibiotic-free DNA vaccine vectors utilizing a novel RNA based plasmid selection system
Luke, J., Carnes, A. E., Hodgson, C. P., & Williams, J. A. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.06.017 · Cited by 114 · cited 1×
“[57]”
New Generation of Plasmid Backbones Devoid of Antibiotic Resistance Marker for Gene Therapy Trials
Vandermeulen, G., Marie, C., Scherman, D., & Véronique Préat, A. (2011) · Molecular Therapy · doi:10.1038/mt.2011.182 · Cited by 113 · cited 2×
“Although kanamycin selection marker remains allowed for gene therapy clinical trials [95,96] the first steps to increase biosafety have been performed using antibiotic-free plasmids in clinical models [76].”
BackgroundWegerer, A., Sun, T., & Altenbuchner, J. (2008) · BMC Biotechnology · doi:10.1186/1472-6750-8-2 · Cited by 111 · cited 1×
“The ccdB/ccdA toxin/antitoxin pair is also used by several authors [48,79], by cloning the entire locus on the plasmid to allow its stabilization in E.”
MethodResistance to Tellurite as a Selection Marker for Genetic Manipulations of Pseudomonas Strains
Sánchez-Romero, J. M., Díaz‐Orejas, R., & de Lorenzo, V. (1998) · Applied and Environmental Microbiology · doi:10.1128/aem.64.10.4040-4046.1998 · Cited by 111 · cited 1×
“resistance on plasmid Bioconversion of toluene Sanchez-romero [52]”
BackgroundpCOR: a new design of plasmid vectors for nonviral gene therapy
Soubrier, F., Cameron, B., Manse, B., Somarriba, S., Dubertret, C., Jaslin, G., Jung, G., Caer, C. L., Dang, D., Mouvault, J. M., et al. (1999) · Gene Therapy · doi:10.1038/sj.gt.3300968 · Cited by 108 · cited 3×
“Both plasmid and chromosome are in a mutually dependent, leading to a safer DNA vector that is unable to replicate in environmental bacterial strains [39].”
BackgroundMethodInfluentialNovel Minicircle Vector for Gene Therapy in Murine Myocardial Infarction
Huang, M., Chen, Z., Hu, S., Jia, F., Li, Z., Hoyt, G. E., Robbins, R. C., Kay, M. A., & Wu, J. C. (2009) · Circulation · doi:10.1161/circulationaha.108.841155 · Cited by 100 · cited 1×
“[67]”
Finch, R., & Hunter, P. A. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl373 · Cited by 100
Vidal, L., Pinsach, J., Striedner, G., Caminal, G., & Ferrer, P. (2008) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2008.01.011 · Cited by 99 · cited 1×
“[42]”
The hok killer gene family in gram-negative bacteria.
Gerdes, K., Lk, P., Thisted, T., Nielsen, A. K., Martinussen, J., & Andreasen, P. (1990) · PubMed · Cited by 98
Introduction: the challenge of multiresistance
Livermore, D. M. (2007) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(07)00158-6 · Cited by 90 · cited 1×
“The first consequence is the emergence of resistant or even multiresistant pathogenic bacterial strains that has become a general concern promise to even further increase [1].”
BackgroundBloor, A. E., & Cranenburgh, R. M. (2006) · Applied and Environmental Microbiology · doi:10.1128/aem.72.4.2520-2525.2006 · Cited by 88 · cited 1×
“Upon transformation and chromosomal insertion, the recombinases resolve the two directly repeated dif sites to a single site, excising the antibiotic resistance gene [73].”
Mattia, A., & Merker, R. (2008) · Clinical Infectious Diseases · doi:10.1086/523329 · Cited by 86 · cited 1×
“This group of biological agents is clearly distinct from old live attenuated vaccines and contains diverse technologies such as genetically attenuated pathogenic strains, GRAS [106] microorganisms (Generally Recognized As Safe) used as delivery vehicles or viral strains carrying foreign antigens.”
Backgroundda Costa, A. C., Nogueira, S. V., Kipnis, A., & Junqueira‐Kipnis, A. P. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00152 · Cited by 85 · cited 1×
“A recombinant version of the extensively used BCG strain is the basis of a new strategy to improve long-lasting memory response and overcome the relative lack of efficiency of the original vaccine formula [109].”
BackgroundNew technologies in developing recombinant attenuated Salmonella vaccine vectors
Wang, S., Kong, Q., & Curtiss, R. (2012) · Microbial Pathogenesis · doi:10.1016/j.micpath.2012.10.006 · Cited by 84
Regulatable killing of eukaryotic cells by the prokaryotic proteins Kid and Kis
Mendez, G. A., Mills, A. D., Clay‐Farrace, L., Díaz‐Orejas, R., & Laskey, R. A. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg026 · Cited by 78
Marie, C., Vandermeulen, G., Quiviger, M., Richard, M., Véronique Préat, A., & Scherman, D. (2010) · The Journal of Gene Medicine · doi:10.1002/jgm.1441 · Cited by 75
Safety and efficacy of DNA vaccines
Stenler, S., Blomberg, P., & Smith, C. E. (2014) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.28077 · Cited by 74
Plasmid selection in Escherichia coli using an endogenous essential gene marker
Goh, S., & Good, L. (2008) · BMC Biotechnology · doi:10.1186/1472-6750-8-61 · Cited by 72 · cited 2×
“Based on this strategy, resistance to Triclosan can be provided by the expression of the plasmid-born Fabl gene Goh and Good [53].”
BackgroundImproving DNA Vaccine Performance Through Vector Design
Williams, J. (2014) · Current Gene Therapy · doi:10.2174/156652321403140819122538 · Cited by 68 · cited 1×
“To better understand the mechanism of action of all the antibiotic-free selection and maintenance systems, reviews including schematic have been recently published [28,76,91,92].”
BackgroundAntibiotic-free selection in E. coli: new considerations for optimal design and improved production
Peubez, I., Chaudet, N., Mignon, C., Hild, G., Husson, S., Courtois, V., Luca, K. D., Speck, D., & Sodoyer, R. (2010) · Microbial Cell Factories · doi:10.1186/1475-2859-9-65 · Cited by 68 · cited 4×
“To better understand the mechanism of action of all the antibiotic-free selection and maintenance systems, reviews including schematic have been recently published [28,76,91,92].”
BackgroundMethodInfluentialSelf-citationMarker-free plasmids for biotechnological applications – implications and perspectives
Oliveira, P. H., & Mairhofer, J. (2013) · Trends in biotechnology · doi:10.1016/j.tibtech.2013.06.001 · Cited by 67 · cited 1×
“To better understand the mechanism of action of all the antibiotic-free selection and maintenance systems, reviews including schematic have been recently published [28,76,91,92].”
BackgroundCombining the hok/sok, parDE, and pnd postsegregational killer loci to enhance plasmid stability
Pecota, D. C., Kim, C. S., Wu, K., Gerdes, K., & Wood, T. K. (1997) · Applied and Environmental Microbiology · doi:10.1128/aem.63.5.1917-1924.1997 · Cited by 64 · cited 1×
“the parB locus, also identified as hok/sok, is used for plasmid maintenance since 1986 [44] and have also been combined with parDE [45].”
BackgroundA system of vectors for Bacillus subtilis spore surface display
Iwanicki, A., Piątek, I., Stasiłojć, M., Grela, A., Łęga, T., Obuchowski, M., & Hinc, K. (2014) · Microbial Cell Factories · doi:10.1186/1475-2859-13-30 · Cited by 64 · cited 1×
“[61]”
Plasmid‐free T7‐based Escherichia coli expression systems
Striedner, G., Pfaffenzeller, I., Markus, L., Nemecek, S., Grabherr, R., & Bayer, K. (2010) · Biotechnology and Bioengineering · doi:10.1002/bit.22598 · Cited by 63 · cited 1×
“[62] developed a plasmid-free, T7-based E.”
Zhang, X., Epperly, M. W., Kay, M. A., Chen, Z.-Y., Dixon, T., Franicola, D., Greenberger, B. A., Komanduri, P., & Greenberger, J. S. (2008) · Human Gene Therapy · doi:10.1089/hum.2007.141 · Cited by 62
Regulatory evaluation of Glybera in Europe — two committees, one mission
Melchiorri, D., Pani, L., Gasparini, P., Cossu, G., Ancāns, J., Borg, J.-J., Drai, C., Fiedor, P. S., Flory, E., Hudson, I., et al. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3835-c1 · Cited by 60 · cited 1×
“Glybera is a replication-deficient, adenovirus associated virus type 1 (AAV1) vector, containing a CMV promoter and expressing Ser447X variant of the human LPL gene [104].”
BackgroundA novel antibiotic free plasmid selection system: Advances in safe and efficient DNA therapy
Mairhofer, J., Pfaffenzeller, I., Merz, D., & Grabherr, R. M. (2007) · Biotechnology Journal · doi:10.1002/biot.200700141 · Cited by 60 · cited 2×
“growth [56].”
Garmory, H. S., Leckenby, M. W., Griffin, K. F., Elvin, S. J., Taylor, R. R., Hartley, M. G., Hanak, J. A. J., Williamson, E. D., & Cranenburgh, R. M. (2005) · Infection and Immunity · doi:10.1128/iai.73.4.2005-2011.2005 · Cited by 57 · cited 1×
“[60]”
(2010) · Nutrition & Food Science · doi:10.1108/nfs.2010.01740cab.009 · Cited by 57
Engineering of bacterial strains and vectors for the production of plasmid DNA
Bower, D. M., & Prather, K. L. J. (2009) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-009-1889-8 · Cited by 56 · cited 1×
“Process optimization is a way to improve productivity, nevertheless the nature and design of the construct and recent innovations in strain and vector engineering or alterations of the host genome or vector backbone are more likely to dramatically increase production of plasmid DNA [30].”
BackgroundSzpirer, C., & Milinkovitch, M. C. (2005) · BioTechniques · doi:10.2144/05385rr02 · Cited by 53 · cited 1×
“developed a “separate component” system where toxin is carried by the chromosome and the antidote is brought by the plasmid [49] (Scheme3B).”
BackgroundAntibiotics: the changing regulatory and pharmaceutical industry paradigm
Bax, R. P., & Green, S. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku572 · Cited by 52 · cited 1×
“The improvement of existing antibiotics and discovery of new molecules is, by definition, an endless quest [2,3].”
BackgroundThe Art of Selective Killing: Plasmid Toxin/Antitoxin Systems and their Technological Applications
Stieber, D., Gabant, P., & Szpirer, C. (2008) · BioTechniques · doi:10.2144/000112955 · Cited by 52 · cited 1×
“The ccdB/ccdA toxin/antitoxin pair is also used by several authors [48,79], by cloning the entire locus on the plasmid to allow its stabilization in E.”
MethodLin, D., Li, Y., Zhou, Q., Xu, Y., & Wang, D. (2014) · Ecotoxicology · doi:10.1007/s10646-014-1320-9 · Cited by 50 · cited 1×
“The toxicity of triclosan was evaluated in a rat model through exposure to aerosol inhalation [88] and its potential effect on DNA damage and reproduction was also demonstrated [89].”
BackgroundSynthetic biology devices and circuits for RNA-based ‘smart vaccines’: a propositional review
Andries, O., Kitada, T., Bodner, K., Sanders, N. N., & Weiss, R. (2015) · Expert Review of Vaccines · doi:10.1586/14760584.2015.997714 · Cited by 49 · cited 1×
“is the use of RNA-based nucleic acid vaccination [101,102].”
BackgroundFiedler, M. R. M., & Skerra, A. (2001) · Gene · doi:10.1016/s0378-1119(01)00629-1 · Cited by 46
Cranenburgh, R. M., Lewis, K. S., & Hanak, J. A. J. (2004) · Microbial Physiology · doi:10.1159/000079828 · Cited by 45 · cited 1×
“The presence, in the host, of a high copy number plasmid containing the lac operator (lacO) releases the repression of dapD expression through titration of LacI from the operator [59].”
BackgroundArmengol, G., Ruíz, L. M., & Ordúz, S. (2004) · Molecular Biotechnology · doi:10.1385/mb:27:2:109 · Cited by 43 · cited 1×
“have used in situ hybridization and PCR to document persistence of a plasmid harboring the cry11Bb gene of Bacillus up to two years after injection in mouse muscle [5].”
MethodGalen, J. E., Wang, J. Y., Chinchilla, M., Vindurampulle, C., Vogel, J. E., Levy, H., Blackwelder, W. C., Pasetti, M. F., & Levine, M. M. (2009) · Infection and Immunity · doi:10.1128/iai.00916-09 · Cited by 43
Dong, W.-R., Xiang, L., & Shao, J.-Z. (2010) · Applied and Environmental Microbiology · doi:10.1128/aem.02462-09 · Cited by 42 · cited 1×
“[43]”
Ryan, E. T., Crean, T. I., Kochi, S. K., John, M., Luciano, A. A., Killeen, K., Klose, K. E., & Calderwood, S. B. (2000) · Infection and Immunity · doi:10.1128/iai.68.1.221-226.2000 · Cited by 41 · cited 1×
“[36]”
Codon bias, tRNA pools, and horizontal gene transfer
Tuller, T. (2011) · Mobile Genetic Elements · doi:10.4161/mge.1.1.15400 · Cited by 40 · cited 1×
“Horizontal genetic transfer (HGT), an important driving force in bacterial evolution, is the passage of genetic elements between organisms [9,10].”
BackgroundSelvamani, R. S. V., Telaar, M., Friehs, K., & Flaschel, E. (2014) · Microbial Cell Factories · doi:10.1186/1475-2859-13-58 · Cited by 39
Gene-deleted live-attenuatedTrypanosoma cruziparasites as vaccines to protect against Chagas disease
Sánchez-Valdéz, F. J., Brandán, C. P., Ferreira, A., & Basombrio, M. A. (2014) · Expert Review of Vaccines · doi:10.1586/14760584.2015.989989 · Cited by 38 · cited 1×
“response [107].”
Diago‐Navarro, E., Hernández‐Arriaga, A. M., López‐Villarejo, J., Muñoz‐Gómez, A. J., Kamphuis, M. B., Boelens, R., Lemonnier, M., & Díaz‐Orejas, R. (2010) · FEBS Journal · doi:10.1111/j.1742-4658.2010.07722.x · Cited by 35
Morona, R., Brown, M. H., Yeadon, P. J., Heuzenroeder, M. W., & Manning, P. A. (1991) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1991.tb04895.x · Cited by 35 · cited 1×
“[35]”
Therapeutic Antibody Gene Transfer: An Active Approach to Passive Immunity
Bakker, J. M., Bleeker, W. K., & Parren, P. W. H. I. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2004.06.865 · Cited by 34 · cited 1×
“For specific therapeutic agents or fields of application such as DNA vaccination, passive immunization using antibody gene transfer [4] or gene therapy, the presence of an antibiotic resistant gene in the vector backbone is rightly pointed out as undesirable by health authorities.”
BackgroundChang, C., Christensen, L. V., Lee, M., & Kim, S. W. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.10.014 · Cited by 34 · cited 1×
“[66]”
Challenges in developing new antibacterial drugs.
Williams, K. J., & Bax, R. P. (2009) · PubMed · Cited by 33
Stability of a host-vector system based on complementation of an essential gene in Escherichia coli
Degryse, E. (1991) · Journal of Biotechnology · doi:10.1016/0168-1656(91)90233-l · Cited by 33 · cited 1×
“Escherichia coli dapD mutation → DAP auxotrohpy dapD No DNA and protein expression Degryse, [32]”
BackgroundSchweder, T., Schmidt, I., Herrmann, H., Neubauer, P. B., Hecker, M., & Hofmann, K. H. (1992) · Applied Microbiology and Biotechnology · doi:10.1007/bf00169425 · Cited by 32 · cited 1×
“[46]”
Trombert, A. N. (2014) · Beneficial Microbes · doi:10.3920/bm2014.0068 · Cited by 32 · cited 1×
“Lactic acid bacteria and other commensal hosts are candidates of choice for the design of novel oral vaccines and possible alternatives to attenuated pathogens [108].”
BackgroundLiang, A., Riaz, H., Dong, F., Luo, X., Yu, X., Han, Y., Chong, Z., Li, H., Guo, A., & Yang, L. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.01.026 · Cited by 26 · cited 3×
“[6] evaluated the efficacy, biodistribution and safety of plasmid delivered by the strain C501.”
BackgroundMethodInfluentialA New Strategy to Deliver Synthetic Protein Drugs: Self-reproducible Biologics Using Minicircles
Yi, H., Kim, Y., Kim, J., Jung, H., Rim, Y. A., Jung, S. M., Park, S., & Ju, J. H. (2014) · Scientific Reports · doi:10.1038/srep05961 · Cited by 25 · cited 1×
“[69]”
-Lactamase and the Resistance of Pseudomonas aeruginosa to Various Penicillins and Cephalosporins
Garber, N. C., & FRIEDMAN, J. (1970) · Journal of General Microbiology · doi:10.1099/00221287-64-3-343 · Cited by 25 · cited 1×
“A marked β-lactamase activity was also measured in various Pseudomonas aeruginosa resistant strains in the early seventies [12].”
BackgroundBalding, C., Blaby, I. K., & Summers, D. (2006) · Plasmid · doi:10.1016/j.plasmid.2005.12.001 · Cited by 25 · cited 1×
“Rcd is transcribed from the Pcer promoter in plasmid dimers, but not in monomers, and is a key component of the checkpoint that delays the division of dimeror multimercontaining cells [26].”
BackgroundEvaluation of toxicity to triclosan in rats following 28 days of exposure to aerosol inhalation
Yang, Y., Kwon, J., Shim, I., Kim, H.-M., Kim, P., Kim, J.-C., & Lee, K. (2015) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2015.01.004 · Cited by 24 · cited 1×
“The toxicity of triclosan was evaluated in a rat model through exposure to aerosol inhalation [88] and its potential effect on DNA damage and reproduction was also demonstrated [89].”
BackgroundImprovement of pCOR plasmid copy number for pharmaceutical applications
Soubrier, F., Laborderie, B., & Cameron, B. (2004) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-004-1729-9 · Cited by 24 · cited 1×
“A particular combination of copy-up mutations was shown to produce a 3-5-fold increase in plasmid DNA per biomass unit [75].”
BackgroundUsing the nucleotide substitution rate matrix to detect horizontal gene transfer
Hamady, M., Betterton, M. D., & Knight, R. D. (2006) · BMC Bioinformatics · doi:10.1186/1471-2105-7-476 · Cited by 24 · cited 1×
“Recent technological breakthroughs, such as the one that can be observed for next generation sequencing, offers unthinkable and extensive possibilities of detecting numerous HGT events, especially if the data acquisition is completed by new bioinformatics tools like nucleotide substitution rate matrixes [14].”
BackgroundPfaffenzeller, I., Mairhofer, J., Striedner, G., Bayer, K., & Grabherr, R. M. (2006) · Biotechnology Journal · doi:10.1002/biot.200600017 · Cited by 22 · cited 1×
“An alternative and novel plasmid addiction model, based on ColE1 derived RNAI properties was suggested by Pfaffenzeller et al.[55].”
Huang, J.-M., Sali, M., Leckenby, M. W., Radford, D. S., Huynh, H. A., Delogu, G., Cranenburgh, R. M., & Cutting, S. M. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.09.001 · Cited by 22 · cited 1×
“In addition to plasmid DNA production, the ORT® system has been adapted for vaccine delivery using Salmonella enterica live bacterial vectors [72].”
MethodToxin–antitoxin based transgene expression in mammalian cells
Nehlsen, K., Herrmann, S., Zauers, J., Häuser, H., & Wirth, D. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp1140 · Cited by 21 · cited 1×
“[51]”
Stable expression plasmids for Streptomyces based on a toxin-antitoxin system
Sevillano, L., Díaz, M., & Santamaría, R. I. (2013) · Microbial Cell Factories · doi:10.1186/1475-2859-12-39 · Cited by 20 · cited 1×
“Interestingly, separated components toxin/antitoxin stabilization systems have been developed for protein production in Streptomces lividans, using YoeBsl gene on the chromosome and YefMsl gene on the plasmid [50].”
MethodAntibiotic-free production of a herpes simplex virus 2 DNA vaccine in a high yield cGMP process
Nelson, J. L., Rodriguez, S. A., Finlayson, N., Williams, J. A., & Carnes, A. E. (2013) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.25048 · Cited by 19 · cited 1×
“One can mention the work done by Nelson et al.[105] on herpes simplex virus 2 with a DNA construct incorporating the regulatory agency compliant, minimal, antibiotic-free (AF) NTC8485 mammalian expression vector.”
MethodJawale, C. V., & Lee, J. H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078193 · Cited by 19 · cited 1×
“Salmonella enteritidis Δasd → DAP auxotrophy asd No Ghost vaccine, live vaccine Jawale lee, [41]”
BackgroundMetabolic and Translational Efficiency in Microbial Organisms
Raiford, D. W., Heizer, E. M., Miller, R. V., Doom, T. E., Raymer, M. L., & Krane, D. E. (2012) · Journal of Molecular Evolution · doi:10.1007/s00239-012-9500-9 · Cited by 17 · cited 1×
“It is nevertheless difficult to evaluate the real cost of compensating for auxotrophy [74].”
BackgroundTuntufye, H. N., & Goddeeris, B. M. (2011) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2011.02421.x · Cited by 15 · cited 1×
“With the development of seamless genomic integration by lambda red integrase [84], this kind of system is more and more accessible to easy establishment but cannot be considered for plasmid-based applications.”
BackgroundWarrack, S. R., Panjikar, P., Duster, M. N., & Safdar, N. (2014) · Beneficial Microbes · doi:10.3920/bm2013.0062 · Cited by 15
Steif, A., & Meyer, I. M. (2012) · RNA Biology · doi:10.4161/rna.22746 · Cited by 14
The role of FIS in the Rcd checkpoint and stable maintenance of plasmid ColE1
Blaby, I. K., & Summers, D. (2009) · Microbiology · doi:10.1099/mic.0.029777-0 · Cited by 14 · cited 1×
“FIS appears to have little or no influence on cer-mediated recombination, but, along with XerC and XerD, is required for proper regulation of the Pcer promoter [27].”
BackgroundReschner, A., Scohy, S., Vandermeulen, G., Daukandt, M., Jacques, C., Michel, B., Nauwynck, H., Xhonneux, F., Véronique Préat, A., Vanderplasschen, A. F. C., et al. (2013) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.25086 · Cited by 14
Development of Antibiotic-Free Selection System for Safer DNA Vaccination
Luke, J. M., Carnes, A. E., & Williams, J. A. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-0410-5_6 · Cited by 13 · cited 1×
“[57,82]).”
Recombinant Salmonella Bacteria Vectoring HIV/AIDS Vaccines
Chin’ombe, N. (2013) · The Open Virology Journal · doi:10.2174/1874357901307010121 · Cited by 10 · cited 2×
“The pORT vector was chosen to develop a HIV-1 DNA vaccine, and its delivery induced a specific immune response in patients [99].”
BackgroundKhan, R., Lee, M. H., Joo, H. J., Jung, Y.-H., Ahmad, S., Choi, J.-H., & Lee, S. (2015) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.1407.07021 · Cited by 8 · cited 1×
“Finally, triclosan, widely used as a biocide, was also shown to induce resistance in Aeromonas salmonicida, a pathogen bacteria for fish [90].”
BackgroundYuan, S., Wang, P., Tao, H., Liu, X., Wang, Y., Zhan, D., Liu, C., & Zhang, Z.-S. (2006) · Acta Biochimica et Biophysica Sinica · doi:10.1111/j.1745-7270.2006.00232.x · Cited by 4 · cited 2×
“The lambda-Red technology was used to replace the first cassette by the aspartate-semialdehyde dehydrogenase gene (asd) and the expression levels of the two antigens K88ac fimbriae and heat-labile enterotoxin B subunit (LTB) in cell lysate were proven equivalent to MM-3 [111].”
Method
Research works printed but not linked: 1
- WHO (2005, January 24–28). Guidelines for assuring the quality of non clinical safety evaluation of DNA vaccines. Proceedings of the 56th Meeting of the WHO Expert Committee on Biological Standardization, Geneva, Switzerland.
Cited by
Tumour-targeting bacteria engineered to fight cancer
Zhou, S., Gravekamp, C., Bermudes, D., & Liu, K. (2018) · Nature Reviews Cancer · doi:10.1038/s41568-018-0070-z · Cited by 821
'Deadman' and 'Passcode' microbial kill switches for bacterial containment
Chan, C. T. Y., Lee, J. W., Cameron, D. E., Bashor, C. J., & Collins, J. J. (2016) · Nature Chemical Biology · doi:10.1038/nchembio.1979 · Cited by 399
Platforms for Production of Protein-Based Vaccines: From Classical to Next-Generation Strategies
Cid, R., & Bolívar, J. (2021) · Biomolecules · doi:10.3390/biom11081072 · Cited by 176
Safety Aspects of Genetically Modified Lactic Acid Bacteria
Plavec, T. V., & Berlec, A. (2020) · Microorganisms · doi:10.3390/microorganisms8020297 · Cited by 156
“According to their mechanisms of action, these systems can be based on auxotrophic, nonantibiotic dominant and complementary markers, post-segregational killing, RNA interference, or de-repression of an essential gene or minicircle [88].”
BackgroundDNA Vaccines: Their Formulations, Engineering and Delivery
Kozak, M., & Hu, J. (2024) · Vaccines · doi:10.3390/vaccines12010071 · Cited by 115
“This has led to a concern about antibiotic resistance as a possible adverse effect of DNA vaccination should the antibiotic resistance gene be integrated [203].”
Background
Metadata
- Authors
- Mignon, C., Sodoyer, R., & Werle, B.
- Affiliations
- BIOASTER (FR)
- Corresponding author
- Sodoyer, Régis
- ORCID
- Mignon, Charlotte
- Venue
- Pathogens
- Publisher
- MDPI AG
- Published
- 2015-04-03
- Volume
- 4
- Issue
- 2
- Pages
- 157-181
- ISSN
- 2076-0817 (ISSN-L)
- PMC
- PMC4493468
- OpenAlex
- W2057140623
- Cited by
- 87
- References
- 110
- Citations by year
- 2026: 10 · 2025: 5 · 2024: 9 · 2023: 6 · 2022: 14 · 2021: 12 · 2020: 7 · 2019: 7 · 2018: 7 · 2017: 3 · 2016: 5 · 2015: 2
- FWCI
- 0.72
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Pathogens (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Viral Infectious Diseases and Gene Expression in Insects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Microbial Metabolic Engineering and Bioproduction
- Keywords
- antibiotic-free selection, biopharmaceutical manufacturing, DNA vaccine, gene therapy products, delivery vehicles, molecular engineering
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.